Sorry, you need to enable JavaScript to visit this website.

Fighting Infectious

  • Infectious diseases are caused by pathogens invading the body.

    They fall into four major types.

    Bacterial infections range from relatively minor such as skin or gastrointestinal infections, to serious and life-threatening, such as bloodstream infections or pneumonia. Most bacteria are classified as Gram-positive or Gram-negative.

    Fungal infections range from athlete’s foot or vaginal thrush to life-threatening, invasive infections in immunocompromised patients, such as those with cancer.

    Viral infections range from common, self-resolving colds, to serious, long-term infections like hepatitis C. Vaccinations can help prevent viral infections from occurring in the first place.

    Parasitic infections can affect anyone, anywhere, but are a particular burden on people living in the tropics and subtropics. They’re caused by an organism living on or in a host and  include malaria, toxoplasmosis, and intestinal worms.

  • Anti-infectives are medicines that work to help treat infections. They include antibacterials, antivirals, antifungals, and antiparasitic medications

  • Anti-infectives have revolutionized healthcare.

    Thanks to anti-infective therapies, we now can: 

    • Treat minor infections and many serious infectious diseases, like pneumonia or tuberculosis.
    • Perform routine procedures and complex surgery, such as cesarean sections or joint replacements, which carry a risk of serious infection.
    • Give vital immuno-suppressive treatments, like chemotherapy, to people with cancer 
  • Antimicrobial-resistant infections are those where the pathogen no longer responds to the anti-infective being used as treatment.

    Alarmingly, many anti-infectives are losing their effectiveness due to Antimicrobial Resistance (AMR), which, in turn may cause infections to become increasingly difficult or impossible to treat.

    AMR is therefore widely recognized as one of the biggest threats to global health today.

    A continued rise in AMR could take 10 million lives globally each year by 2050 – more than currently die from cancer.

Anti-infectives underpin modern medicine as we know it, treating or even curing many kinds of infection. Find out how we’re helping to ensure that patients have access to critical anti-infective therapies, and how we’re fighting back against Antimicrobial Resistance (AMR).

Our Centers for Therapeutic Innovation collaborates with academic institutions and investigators to push forward great science, using the depth and breadth of the Pfizer enterprise to accelerate concepts into viable therapies with breakthrough potential for patients.

Find Out More About CTI

Revolutionary medicines enable us to enrich and extend life for people suffering from all types of diseases. 

Rare Disease
View All Rare Disease

Explore all of our disease and condition-related resources to learn more about your diagnosis and treatment options. 

Gene Therapy
Duchenne Muscular Dystrophy 
Gaucher Disease
Growth Hormone Deficiency 
Sickle Cell 
Transthyretin Amyloidosis 

Internal Medicine
View All Internal Medicine

We’re developing therapies to treat, slow, or prevent disease progression and improve the quality of life for patients with obesity, type 2 diabetes, and cardiovascular and kidney diseases. 

Inflammation & Immunology
View All Inflammation & Immunology

We look for treatments that provide more than just symptom relief, in order to address the root cause of chronic inflammatory diseases at a molecular level

View All Vaccines

Vaccines are the single most important innovation in the science of health to significantly reduce the threat of diseases that were once widespread and oftentimes fatal. 

Pipeline & Clinical Trials 

View All Oncology

Cancer treatment needs to be transformed across the entire landscape to significantly improve the lives of cancer patients worldwide.

Biology into medicine
Global Impact

Anti Infectives
View All Anti Infectives

Anti-infectives are medicines that work to prevent or treat infections, including antibacterials, antivirals, antifungals, and antiparasitic medications. 

Antimicrobial Resistance 
AMR Prevention 
Antimicrobial Surveillance 
Antimicrobial Stewardship 
Our Commitment as a Global Leader 
Environmental Protection 

The medicines available today have taken an average of 12 years to develop. With dedication, creativity, and science we can significantly cut that time.

Learn more about the process of joining a clinical trial and find a trial near you.

Go to Pfizer Clinical Trials Site